119 related articles for article (PubMed ID: 16786662)
1. [Systemic enzymotherapy as a method of prophylaxis of postradiation complications in oncological patients].
Hubarieva HO; Kindzel's'kyĭ LP; Ponomar'ova OV; Udatova TV; Shpil'ova SI; Smolanka II; Korovin SI; Ivankin VS
Lik Sprava; 2000; (7-8):94-100. PubMed ID: 16786662
[TBL] [Abstract][Full Text] [Related]
2. [Systemic enzyme therapy in osteosynthesis of the long bones].
Kamenícek V; Holan P
Rozhl Chir; 1999 Jun; 78(6):279-81. PubMed ID: 10596557
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Clinical Trial to Evaluate Efficacy and Tolerability of Trypsin:Chymotrypsin as Compared to Serratiopeptidase and Trypsin:Bromelain:Rutoside in Wound Management.
Chandanwale A; Langade D; Sonawane D; Gavai P
Adv Ther; 2017 Jan; 34(1):180-198. PubMed ID: 27889883
[TBL] [Abstract][Full Text] [Related]
4. [Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling].
Kamenícek V; Holán P; Franĕk P
Acta Chir Orthop Traumatol Cech; 2001; 68(1):45-9. PubMed ID: 11706714
[TBL] [Abstract][Full Text] [Related]
5. [Effect of phlogenzym in long-term treatment of patients with multiple sclerosis].
Mialovyts'ka OA
Lik Sprava; 2003; (3-4):109-13. PubMed ID: 12889375
[TBL] [Abstract][Full Text] [Related]
6. A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 29.
Ranchordas MK; Burd N; Senchina DS; Burke LM; Stear SJ; Castell LM
Br J Sports Med; 2012 Feb; 46(2):155-6. PubMed ID: 22241933
[No Abstract] [Full Text] [Related]
7. [Effect of flogensim in the treatment of postischemic inflammation (according to results of using interleukin-6 in patients with acute brain infarction)].
Vinychuk SM; Cheren'ko TM
Lik Sprava; 2007; (3):80-4. PubMed ID: 18271187
[TBL] [Abstract][Full Text] [Related]
8. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes.
Kerkhoffs GM; Struijs PA; de Wit C; Rahlfs VW; Zwipp H; van Dijk CN
Br J Sports Med; 2004 Aug; 38(4):431-5. PubMed ID: 15273178
[TBL] [Abstract][Full Text] [Related]
9. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects.
Dale PS; Tamhankar CP; George D; Daftary GV
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S29-34. PubMed ID: 11561869
[TBL] [Abstract][Full Text] [Related]
10. [Proteolytic enzymes as an alternative in comparison with nonsteroidal anti-inflammatory drugs (NSAID) in the treatment of degenerative and inflammatory rheumatic disease: systematic review].
Heyll U; Münnich U; Senger V
Med Klin (Munich); 2003 Nov; 98(11):609-15. PubMed ID: 14631536
[TBL] [Abstract][Full Text] [Related]
11. [Peculiarities of post-infarct remodeling using a complex treatment including system ensymotherapeutics].
Mel'nichenko OV; Nekrasov AA; Knorring GIu; Lobanova NIu
Voen Med Zh; 2007 Dec; 328(12):25-30. PubMed ID: 18314784
[No Abstract] [Full Text] [Related]
12. [The use of enzymes in treating patients with malignant lymphoma with a large tumor mass].
Gubareva AA
Lik Sprava; 1998 Aug; (6):141-3. PubMed ID: 9844901
[TBL] [Abstract][Full Text] [Related]
13. [Application of systemic enzyme therapy in combined treatment of patients with pulmonary cancer and malignant thymoma].
Hanul VL; Smolanka II; Ponomar'ova OV
Klin Khir; 2000 Jun; (6):17-9. PubMed ID: 11288269
[TBL] [Abstract][Full Text] [Related]
14. [Antigen induced experimental arthritis as a testing method for anti-inflammatory effects of orally administered substances].
Steffen C; Zeitlhofer J; Menzel J; Smolen J
Z Rheumatol; 1979; 38(7-8):264-78. PubMed ID: 506489
[No Abstract] [Full Text] [Related]
15. Systemic proteolytic enzyme treatment diminishes urinary interleukin 6 in diabetic patients.
Paczek L; Kropiewnicka EH; Bartlomiejczyk I; Gradowska L; Heidland A; Wood G
Nephron; 2000 Feb; 84(2):194-5. PubMed ID: 10657726
[No Abstract] [Full Text] [Related]
16. [Oral enzyme therapy in osteoarthritis of the knee. Proteolytic enzyme are effective with few risks].
MMW Fortschr Med; 2001 Jun; 143(23):44-6. PubMed ID: 11460424
[No Abstract] [Full Text] [Related]
17. [Impact of exogenous proteolytic enzymes on immunogenesis in patients with urogenital infections].
Khrianin AA; Reshetnikov OV; Safronov ID
Antibiot Khimioter; 2012; 57(9-10):25-7, 29-31. PubMed ID: 23477217
[TBL] [Abstract][Full Text] [Related]
18. [Oral enzyme therapy for chronic hepatitis C--a retrospective analysis].
Huber R; Futter I; Goedl R; Rostock M; Lüdtke R
Forsch Komplementarmed Klass Naturheilkd; 2005 Jun; 12(3):144-7. PubMed ID: 15985778
[TBL] [Abstract][Full Text] [Related]
19. Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
Desser L; Holomanova D; Zavadova E; Pavelka K; Mohr T; Herbacek I
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S10-5. PubMed ID: 11561866
[TBL] [Abstract][Full Text] [Related]
20. [The local immunity of the urinary system in patients with recurrent urolithiasis].
Borisov AV
Lik Sprava; 1999; (3):111-5. PubMed ID: 10474953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
